Niagen Bioscience, Inc. (NASDAQ:NAGE) Receives Average Rating of "Moderate Buy" from Brokerages
MarketBeat
ZTE hit by US foreign bribery probe with fines exceeding US$1bn
DigiTimes: IT news from Asia
How to use the new Linux terminal on your Android device - it's easy
ZDNet: Between the Lines
ZTE Shares Down On Reports Of Possible $1 Bln Fine To US Govt
Nasdaq News: Markets
How Investors Are Reacting To Silgan Holdings (SLGN) Expanding Closures Segment Through Cash-Funded Acquisitions
Simply Wall St
ZTE Under Investigation for FCPA Compliance
TipRanks Financial Blog
Stifel Maintains Ligand Pharmaceuticals Incorporated - Equity Right (LGNXZ) Buy Recommendation
Nasdaq News: Stocks
RBC Capital Maintains Ligand Pharmaceuticals Incorporated - Equity Right (LGNXZ) Outperform Recommendation
Nasdaq News: Stocks
i-mobile Co., Ltd. Records Deferred Tax Benefit in Q1 Financials
TipRanks Financial Blog
i-mobile Reports Surge in Sales but Decline in Profits for Q3 2025
TipRanks Financial Blog
Samsung's Trifold phone launch in China to challenge Huawei dominance
DigiTimes: IT news from Asia
